MedTrace Logo

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

NCT04543266 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-09-11

No results posted yet for this study

Summary

Application Management Team:

PI - Siu Wai Choi; email - [email protected] Delegates - Chui Shan Chu; email: [email protected] FollowUpUsers - Chui Shan Chu; email:[email protected]

Conditions

  • Oral Squamous Cell Carcinoma

Interventions

PROCEDURE

Surgery

Resection of tumors

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-07
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04543266 on ClinicalTrials.gov